Back to ArticlesThe Carcino Foundation
12 min read•Sep 25, 2026

Pancreatic Cancer: Exocrine Adenocarcinoma, CA19-9 Markers, Whipple Surgery & Diet

R

Riddhima Saha | Researcher

Carcino Research & Clinical Advisory

Pancreatic cancer develops in exocrine digestive enzyme cells (93% ductal adenocarcinoma) or endocrine hormone cells. Low 5-year survival rate (~12%).

Location, Causes & Symptoms

Location: 65-70% occur in the head of pancreas near duodenum.

Causes: DNA mutations, tobacco smoking, type 2 diabetes, obesity, family history (Lynch/BRCA), chronic pancreatitis, heavy alcohol.

Symptoms: Belly pain to back, appetite/weight loss, Jaundice (yellow skin/eyes), light floating stool, dark urine, itchy skin, worsening diabetes, fatigue.

Diagnostics & Whipple Resection

Diagnostics: Ultrasound, CT, MRI, PET, Endoscopic Ultrasound (EUS) with Fine Needle Aspiration (FNA) biopsy, CA19-9 tumor marker blood test, Genetic testing.

Treatment: Chemotherapy, Radiation, Targeted therapy, Immunotherapy, Surgery (Whipple procedure pancreaticoduodenectomy), Palliative care.

Maintenance: Pancreatic enzyme supplements (PERT), small frequent meals, blood sugar monitoring.

Frequently Asked Questions (FAQs)

Citations & Medical References